524661 — Welcure Drugs and Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.05bn
- IN₹2.08bn
- IN₹245.50m
- 16
- 31
- 76
- 34
Annual cashflow statement for Welcure Drugs and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | — | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.551 | 0.236 | 1.02 | -1.75 | 27.8 |
| Depreciation | |||||
| Changes in Working Capital | -0.129 | -0.05 | 0.052 | 0.114 | -2,248 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.422 | 0.186 | 1.07 | -1.27 | -2,220 |
| Capital Expenditures | — | — | — | — | -0.17 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0 | 13.2 | 1.65 | -0.465 |
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | 13.2 | 1.65 | -0.635 |
| Financing Cash Flow Items | 0 | 0 | -14.9 | -0.171 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 0 | -14.9 | -0.171 | 2,222 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.422 | 0.186 | -0.648 | 0.204 | 1.07 |